Zusammenfassung
Gemäß internationaler Übereinkunft werden die Adenokarzinome des gastroösophagealen Übergangs, in Kurzform auch als AEG bezeichnet, als eigene Entität verstanden (Stein et al. 2000). Diese allgemein akzeptierte Auffassung wird durch epidemiologische Untersuchungen gestützt, die einheitlich eine kontinuierliche Zunahme der Inzidenz der AEG zeigen (Cameron et al. 1995; DeMeester u. DeMeester 2000; Devesa et al. 1998; . Abb. 39.1), es scheinen also Gemeinsamkeiten in der Onkogenese dieses Tumortyps zu bestehen (DeMeester u. DeMeester 2000; Wijnhoven et al. 1999). Klar ist auch, dass die AEG nicht mit dem Plattenepithelkarzinom der Speiseröhre oder mit dem typischen Magenkarzinom des mittleren und distalen Drittels verglichen werden können (Siewert et al. 1987; Siewert u. Stein 1996). Dennoch umfasst der Begriff AEG bei allen Gemeinsamkeiten verschiedene Tumorsubgruppen, die tumorbiologisch und damit auch prognostisch unterschiedlich zu sehen sind. Unter diesen Gesichtspunkten, aber auch, um Literaturergebnisse miteinander besser vergleichen zu können und adäquate therapeutische Konsequenzen ziehen zu können, ist eine Klassifikation der AEG wünschenswert (Fein et al. 1998; Husemann 1989; Kodera et al. 1999; Siewert et al. 1987; Siewert u. Stein 1996, 1998).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aikou T, Shimazu H (1989) Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Jpn J Surg 19: 290–295
Barbour AP, Lagergreen P, Hughes R, Alderson D, Barham, CP, Blazeby JM (2008) Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg 95:80–84
Bumm R, Feussner H, Bartels H, Stein HJ, Dittler HJ, Höfler H, Siewert JR (1997) Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma. World J Surg 21: 822–831
Cameron AJ, Lomboy CT, Pera M, Carpenter HA (1995) Adenocarcinoma of the esophagogastric junction and Barrett’ esophagus. Gastroenterology 109: 1541–1546
Clark GW, Smyrk TC, Burdiles P et al. (1994) Is Barrett’s metaplasia the source of adenocarcinomas of the cardia? Arch Surg 129: 609–614
DeMeester SR, DeMeester TR (2000) Columnar mucosa and intestinal metaplasia of the esophagus. Fifty years of controversy. Ann Surg 231: 303–321
Chandrasoma C, Wickramasinghe K, Ma Y, DeMeester T (2007) Adenocarcinomas of the Distal Esophagus and »Gastric Cardia« Are Predominantly Esophageal Carcinomas. Am J Surg Pathol 31:569–575
Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049–2053
Ellis FH Jr, Heatley GJ, Krasna MJ, Williamson WA, Balogh K (1998) Esophagogastrectomy for carcinoma of the esophagus and cardia. A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 113: 836–846
Fein M, Fuchs KH, Ritter MP, Freys SM, Heimbucher J, Staab C, Thiede A (1998) Application of the new classification for cancer of the cardia. Surgery 124: 707–713
Flejou JF, Muzeau F, Potet F, Lepelletier F, Fekete F, Henin D (1994) Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas. Pathol Res Pract 190: 1141–1148
Fleming ID, American Joint Committee on Cancer Classification/AJCC (eds) (2002) AJCC cancer staging manual. Lippincott Williams & Wilkins, Philadelphia
Goldfaden D, Orringer MB, Appelman HD, Kalish R (1986) Adenocarcinoma of the distal esophagus and gastric cardia. Comparison of results of transhiatal esophagectomy and thoracoabdominal esophagogastrectomy. J Thorac Cardiovasc Surg 91: 242–247
Graham AJ, Finley RJ, Clifton JC, Evans KG, Fradet G (1998) Surgical management of adenocarcinoma of the cardia. Am J Surg 175: 418–421
Harrison LE, Karpeh MS, Brennan MF (1997) Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach. Ann Surg 225: 678–683
Hsu CP, Wu CC, Chen CY, Hsu NY, Jiun YH, Wang PY (1997) Clinical experience in radical lymphadenectomy for adenocarcinoma of the gastric cardia. J Thorac Cardiovasc Surg 114: 544–551
Hulscher JB, van Sandick JW, de Boer AG et al. (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347: 1662–1669
Husemann B (1989) Cardia carcinoma considered as a distinct clinical entity. Br J Surg 76: 136–139
Ireland AP, Shibata DK, Chandrasoma P, Lord RV, Peters JH, DeMeester TR (2000) Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann Surg 231: 179–187
Kajiyama Y, Tsurumaru M, Udagawa H, Tsutsumi K, Kinoshita Y, Ueno M, Akiyama H (1997) Prognostic factors in adenocarcinoma of the gastric cardia: Pathologic stage analysis and multivariate regression analysis. J Clin Oncol 15: 2015–2021
Kodera Y, Yamamura Y, Shimizu Y et al. (1999) Adenocarcinoma of the gastroesophageal junction in Japan: Relevance of Siewert’s classification applied to 177 cases resected at a single institution. J Am Coll Surg 189: 594–601
Lagergren J, Bergström R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340: 825–831
Laurén P (1965) The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scan 64: 31–49
Lordick, F, Ruers T, Aust DE et al. (2008) European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer. Eur J Cancer 44:1807–1819
Lordick F, Ott K, Krause BJ et al. (2007) PET to assess early metabolic response and to guide traetment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8:797–805
Mueller J, Stein HJ, Ouyang T, Natsugoe S, Feith M, Werner M, Siewert JR (2000) Frequency and clinical impact of lymph node micrometastases and tumor cell microinvolvement in adenocarcinoma of the esophagogastric junction. Cancer 89: 1874–1882
Omloo JM, Lagarde SM, Hulscher JB et al. (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246(6):992–1000
Ott K, Weber W, Fink U et al. (2003) Fluorodeoxyglucose-PET in adenocarcinoma of the distal esophagus and cardia. World J Surg 27: 1035–1039
Papachristou DN, Fortner JG (1980) Adenocarcinoma of the gastric cardia. The choice of gastrectomy. Ann Surg 192: 58–64
Parshad R, Singh RK, Kumar A, Gupta SD, Chattopadhyay TK (1999) Adenocarcinoma of distal esophagus and gastroesophageal junction: Longterm results of surgical treatment in a North Indian Center. World J Surg 23: 277–283
Sarbia M, Borchard F, Hengels KJ (1993) Histogenetical investigations on adenocarcinomas of the esophagogastric junction. An immunhistochemical study. Pathol Res Pract 189: 530–535
Schneider PM, Schweighart P, Stöltzing O et al. (1997) Molecular evidence that cancer of the cardia is different from Barrett’s cancer and related to proximal third gastric cancer. 2nd International Gastric Cancer Congress 1997; Book of abstracts, p 6
Siewert JR, Stein HJ (1996) Adenocarcinoma of the gastroesophageal junction: Classification, pathology and extent of resection. Dis Esoph 9: 173–182
Siewert JR, Stein HJ (1998) Classification of carcinoma of the oesophagogastric junction. Br J Surg 85: 1457–1459
Siewert JR, Hölscher AH, Becker K, Gössner W (1987) Kardiakarzinom: Versuch einer therapeutisch relevanten Klassifikation. Chirurg 58: 25–34
Siewert JR, Stein HJ, Sendler A, Fink U (1999) Surgical resection for cancer of the cardia. Semin Surg Oncol 17: 125–131
Siewert JR, Feith M, Werner M, Stein HJ (2000) Adenocarcinoma of the esophago-gastric junction: results of surgical therapy based on anatomic-topographic classification in 1002 consecutive patients. Ann Surg 232: 353–361
Siewert JR, Fink U, Sendler A et al. (1997) Gastric cancer. Curr Probl Surg 34: 835–942
Siewert JR, Stein HJ, Feith M (2003) Surgical approach to invasive adenocarcinoma of the distal esophagus (Barrett’s cancer). World J Surg 27: 1058–1061
Siewert JR, Bartels H, Stein HJ (2005) Abdominorechtsthorakale Ösophagoektomie mit intrathorakaler Anastomose beim Barrett-Karzinom. Chirurg 76:588–594
Siewert JR, Lordick F, Ott K et al. (2007) Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome. Ann Surg 246:624–628
Sobin LH, Wittekind C, International Union Against Cancer (UICC) (eds) (2002) TNM Classification of malignant tumors. John Wiley & Sons, New York
Stahl M, Walz MK, Stutschke M et al. (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851–856
Stark SP, Romberg MS, Pierce GE et al. (1996) Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia. Am J Surg 172: 478–481
Stein HJ, Feith M, Mueller J, Werner M, Siewert JR (2000) Limited resection for early adenocarcinoma of the Barrett’s esophagus. Ann Surg 232: 733–742
Stein HJ, von Rahden BHA, Höfler H, Siewert JR (2003) Karzinom des ösophagogastralen Übergangs und Barrett Ösophagus-ein nahezu klares onkologisches Modell? Chirurg 74: 703–708
Stein HJ, Zacherl J, Feith M, Siewert J R (2004) Chirurgie des Adenokarzinoms des gastro-ösophagealen Übergangs. In: Meyer H-J, Buhr HJ, Wilke H (Hrsg) Management des Ösophagus-und Magenkarzinoms. Springer, Berlin Heidelberg New York Tokio, pp 223–230
Stein HJ, Feith M, Siewert JR (2009) Neoadjuvante Therapie im oberen Gastrointestinaltrakt. Chirurg 11:1019–1022
Steup WH, De Leyn P, Deneffe G, van Raemdonck D, Coosemans W, Lerut T (1996) Tumors of the esophagogastric junction. Longterm survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of the pTNM classification. J Thorac Cardiovasc Surg 111: 85–94
Tachimori Y, Kato H, Watanabe H, Sasako M, Konoshita T, Maruyama K (1996) Difference between carcinoma of the lower esophagus and the cardia. World J Surg 20: 507–510
Walsh TN, Noonan N, Hollywood D et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462–467
Wayman J, Dresner SM, Raimes SA, Griffin SM (1999) Transhiatal approach to total gastrectomy for adenocarcinoma of the gastric cardia. Br J Surg 86: 536–540
Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW (1999) Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 86: 529–535
Yonemura Y, Tsugawa K, Fonseca L et al. (1995) Lymph node metastasis and surgical management of gastric cancer invading the esophagus. Hepatogastroenterology 42: 37–42
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Siewert, J.R., Stein, H.J. (2010). Adenokarzinom des gastroösophagealen Übergangs (AEG-Karzinom), sog. Kardiakarzinom. In: Siewert, J.R., Rothmund, M., Schumpelick, V. (eds) Praxis der Viszeralchirurgie Onkologische Chirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03808-2_39
Download citation
DOI: https://doi.org/10.1007/978-3-642-03808-2_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03807-5
Online ISBN: 978-3-642-03808-2
eBook Packages: Medicine (German Language)